- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Src Antibody III-19 / Proto-Oncogene Tyrosine-Protein Kinase Src Antibody targets SRC, a non-receptor tyrosine kinase that regulates signaling pathways involved in cell proliferation, adhesion, migration, differentiation, and survival. Also known as c-Src, SRC is the founding member of the Src family kinases and functions downstream of numerous cell surface receptors, including receptor tyrosine kinases, integrins, and G protein-coupled receptors. Through phosphorylation of specific tyrosine residues, SRC coordinates intracellular responses to extracellular signals and contributes to cytoskeletal organization, cell polarity, and tissue homeostasis.
SRC contains an N-terminal membrane-targeting region, SH3 and SH2 interaction domains, a catalytic SH1 kinase domain, and a C-terminal regulatory tail. N-terminal myristoylation promotes membrane association, positioning SRC near receptor complexes and signaling proteins. Its kinase activity is controlled by intramolecular interactions and regulatory phosphorylation. Phosphorylation of the C-terminal inhibitory tyrosine by C-terminal Src kinase (CSK) stabilizes an inactive conformation, while dephosphorylation and conformational changes facilitate activation. Autophosphorylation within the activation loop further increases catalytic activity. These mechanisms allow SRC to respond rapidly to changes in receptor signaling and cellular adhesion.
Activated SRC interacts with focal adhesion kinase (FAK), paxillin, and other proteins involved in focal adhesion assembly and turnover. These interactions connect integrin signaling to actin cytoskeletal remodeling, cell spreading, and migration. SRC also participates in the RAS-MAPK, PI3K-AKT, and STAT signaling pathways, linking receptor activation to transcriptional regulation, metabolism, and cell survival. Its extensive network of substrates enables SRC to integrate growth factor signaling with mechanical and adhesive cues, influencing epithelial organization, developmental processes, and cellular responses to environmental changes.
Dysregulated SRC activity has been implicated in tumor development and progression, particularly through its effects on proliferation, invasion, migration, and resistance to apoptosis. Elevated SRC signaling has been investigated in colorectal, breast, lung, and other malignancies, where it can cooperate with growth factor receptors and oncogenic pathways. SRC also contributes to normal tissue remodeling and cellular communication, making its regulation important beyond cancer biology. Src Antibody III-19 supports research into SRC expression, kinase-associated signaling networks, and the molecular mechanisms connecting cellular adhesion, growth regulation, and malignant progression.
SRC is a central regulator of growth factor signaling, integrin-mediated adhesion, and cellular migration, making it an important target in signal transduction research.
Optimal dilution of the Src Antibody III-19 / Proto-Oncogene Tyrosine-Protein Kinase Src Antibody should be determined by the researcher.
A synthetic peptide specific to human Src was used as the immunogen for the Src antibody.
Store the Src antibody at -20oC.
c-Src antibody, SRC antibody, Proto-oncogene c-Src antibody, Tyrosine-protein kinase Src antibody, Proto-oncogene tyrosine-protein kinase Src antibody, Src family tyrosine kinase antibody, Cellular Src antibody, p60c-Src antibody, pp60c-Src antibody, c-Src kinase antibody, SRC proto-oncogene antibody, Src signaling protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.